Retraction: Bruton’s tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
Saved in:
Main Author: | Frontiers Editorial Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1561869/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction: X-linked immunodeficient mice with no functional Bruton’s tyrosine kinase are protected from sepsis-induced multiple organ failure
by: Frontiers Editorial Office
Published: (2025-01-01) -
Retraction: A synthetic peptide designed to neutralize lipopolysaccharides attenuates metaflammation and diet-induced metabolic derangements in mice
by: Frontiers Editorial Office
Published: (2025-01-01) -
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01) -
Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax
by: Caroline A. Coughlin, et al.
Published: (2025-02-01) -
Retraction: Bone age assessment based on deep convolutional features and fast extreme learning machine algorithm
by: Frontiers Editorial Office
Published: (2025-02-01)